National Health Act 1953 Arrangements made under subparagraph 100(1)(b)(i) Chemotherapy Pharmaceuticals Access Program (No. PB 4 of 2007) (Cth)
COMMONWEALTH OF AUSTRALIA
National Health Act 1953
ARRANGEMENTS MADE UNDER SUBPARAGRAPH 100(1)(b)(i)
CHEMOTHERAPY PHARMACEUTICALS ACCESS PROGRAM
No. PB 4 of 2007
I, JOAN CORBETT, Assistant Secretary, Pharmaceutical Evaluation Branch, Department of Health and Ageing and Delegate of the Minister for Health and Ageing, pursuant to subparagraph 100(1)(b)(i) of the National Health Act 1953, hereby make the following Arrangements for the purpose of providing that an adequate supply of special pharmaceutical products will be available to persons who are receiving treatment with chemotherapy pharmaceuticals at public hospitals as non-admitted patients, day admitted patients or patients on discharge:
1. These Arrangements commence on 1 January 2007.
2. The Arrangements (No. PB 52 of 2006) under subparagraph 100(1)(b)(i) of the National Health Act 1953 made on 7 November 2006 with effect from 1 December 2006 are, in these Arrangements, referred to as the Principal Arrangements.
3. Schedule 2 to the Principal Arrangements is amended, in respect of the pharmaceutical benefits Oxaliplatin powder for I.V. infusion 50 mg and powder for I.V. infusion 100 mg, by inserting the brand “MX” after the brand “IT” and before the brand “SW” in column 6.
Dated this 1st day of December 2006.
JOAN CORBETT
Assistant Secretary
Pharmaceutical Evaluation Branch
Department of Health and Ageing
Delegate of the Minister for Health and Ageing
0
0
0